RSN-0402

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NameRSN-0402
Drug Alias NameRSN0402RSN-0402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShenzhen Resproly Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Resproly Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A